Evidence map›Paper›PMID 28831382›Full record

ArticleIDCases2017

Shinobu Tamura, Asumi Koyama, Yusuke Yamashita, Chieko Shiotani, Hiromichi Nakamoto, Chiaki Nakamoto, Michio Suzuki, Yoshio Nakano, Koichi Imaoka, Takashi Sonoki and 1 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Shinobu TamuraDepartment of Hematology/Oncology, Wakayama Medical University, Japan.
Asumi KoyamaDepartment of Central Clinical Laboratory, Kinan Hospital, Japan.
Yusuke YamashitaDepartment of Hematology/Oncology, Wakayama Medical University, Japan.
Chieko ShiotaniDepartment of Central Clinical Laboratory, Kinan Hospital, Japan.
Hiromichi NakamotoDepartment of Central Clinical Laboratory, Kinan Hospital, Japan.
Chiaki NakamotoDepartment of Certified Nurse Infection Control, Kinan Hospital, Japan.
Michio SuzukiDepartment of Veterinary Science, National Institute of Infectious Diseases, Japan.
Yoshio NakanoDepartment of Internal Medicine, Kinan Hospital, Japan.
Koichi ImaokaDepartment of Veterinary Science, National Institute of Infectious Diseases, Japan.
Takashi SonokiDepartment of Hematology/Oncology, Wakayama Medical University, Japan.
Tokuzo FujimotoDepartment of Internal Medicine, Kinan Hospital, Japan.
Kinan Hospital · JPWakayama Medical University · JPNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Capnocytophaga canimorsusIatrogenic immunocompromised hostsMethotrexateRheumatoid arthritisSepsis

Identifiers

PMID28831382
PMCPMC5554928
OpenAlexW2745140399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.